Food and Drug Administration
Pediatric Subcommittee
October 30, 2003
Slides
Topical Immunosuppressants, Dr. Bindi Nikhar, MD, FAAP, FDA (HTM) (PPT)
Topical Immunosuppressants (Calcineurin Inhibitors) - Animal Toxicology, Dr. Barbara Hill, PhD, FDA (HTM) (PPT)
Post-Marketing AE Reports of Topical Calcineurin Inhibitors, Dr. Marilyn Pitts, PharmD, FDA (HTM) (PPT)
Studying the Risk of Cancer With Topical Calcineurin Inhibitor Use in Children: Design Issues Dr. Lois LaGrenade, MD MPH, FDA (HTM) (PPT)
Practical and Methodological Issues in Long-Term Follow-Up Studies, Dr. Elizabeth Andrews, PhD, RTI Health Solutions (HTM) (PPT)
United States Cancer Registries, Dr. Phyllis Wingo, PhD, MS, CDC (HTM) (PPT)